Berman Capital Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $0 | Sell |
5
-3
| -38% | – | ﹤0.01% | 2096 |
|
|
2021
Q2 | $0 | Buy |
8
+1
| +14% | – | ﹤0.01% | 1927 |
|
|
2021
Q1 | $0 | Buy |
7
+2
| +40% | – | ﹤0.01% | 1792 |
|
|
2020
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1705 |
|
|
2020
Q3 | – | Sell |
-9
| Closed | – | – | 1632 |
|
|
2020
Q2 | $0 | Buy |
+9
| New | – | ﹤0.01% | 1654 |
|